Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Oral Oncology Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024000967 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553753032884224 |
|---|---|
| author | Rethinam Senthil S. Raghunandhakumar |
| author_facet | Rethinam Senthil S. Raghunandhakumar |
| author_sort | Rethinam Senthil |
| collection | DOAJ |
| format | Article |
| id | doaj-art-84690bb51a8a4961a1dfbad74a588d3c |
| institution | Kabale University |
| issn | 2772-9060 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Oral Oncology Reports |
| spelling | doaj-art-84690bb51a8a4961a1dfbad74a588d3c2025-01-09T06:15:30ZengElsevierOral Oncology Reports2772-90602024-03-019100250Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)Rethinam Senthil0S. Raghunandhakumar1Corresponding author.; Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600 077, Tamilnadu, IndiaDepartment of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600 077, Tamilnadu, Indiahttp://www.sciencedirect.com/science/article/pii/S2772906024000967 |
| spellingShingle | Rethinam Senthil S. Raghunandhakumar Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM) Oral Oncology Reports |
| title | Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM) |
| title_full | Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM) |
| title_fullStr | Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM) |
| title_full_unstemmed | Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM) |
| title_short | Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM) |
| title_sort | helping anti cancer activity of cetuximab erbitux by monoclonal antibody conjugated nanocurcumin in vitro studies on human oral squamous carcinoma cell line oecm |
| url | http://www.sciencedirect.com/science/article/pii/S2772906024000967 |
| work_keys_str_mv | AT rethinamsenthil helpinganticanceractivityofcetuximaberbituxbymonoclonalantibodyconjugatednanocurcumininvitrostudiesonhumanoralsquamouscarcinomacelllineoecm AT sraghunandhakumar helpinganticanceractivityofcetuximaberbituxbymonoclonalantibodyconjugatednanocurcumininvitrostudiesonhumanoralsquamouscarcinomacelllineoecm |